The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 23, 2022

Primary Completion Date

September 13, 2024

Study Completion Date

September 13, 2024

Conditions
Plantar Fasciitis
Interventions
DRUG

Botulinum Toxin A

20 units of Onabotulinum A in 200 µL of saline injected into the flexor digitorum brevis via ultrasound-guidance

DRUG

Dexamethasone

1 mL of 4 mg/mL dexamethasone with 2 mL of 1% lidocaine OR 1 mL of 4 mg/mL dexamethasone, 1 mL of 2% lidocaine and 1 mL saline injected into the plantar fascia

Trial Locations (1)

84148

VA Salt Lake City Health Care System, Salt Lake City

All Listed Sponsors
lead

Western Institute for Veterans Research

OTHER